Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
3.49
-0.05
(-1.41%)
USD |
NASDAQ |
Sep 09, 12:07
Shuttle Pharmaceuticals Holdings Debt to Equity Ratio : 0.064 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.064 |
| December 31, 2025 | 0.103 |
| September 30, 2025 | 0.4786 |
| June 30, 2025 | 0.1978 |
| March 31, 2025 | 0.3361 |
| December 31, 2024 | 1.655 |
| September 30, 2024 | -0.429 |
| June 30, 2024 | 1.442 |
| March 31, 2024 | 0.4652 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.2682 |
| September 30, 2023 | 0.1723 |
| June 30, 2023 | 0.1127 |
| March 31, 2023 | 0.2249 |
| December 31, 2022 | 0.0975 |
| September 30, 2022 | 0.0911 |
| June 30, 2022 | -0.589 |
| March 31, 2022 | -0.6626 |
| December 31, 2021 | -0.6013 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.81M |
| Total Liabilities (Quarterly) | 8.463M |
| Shareholders Equity (Quarterly) | 3.346M |
| Current Ratio | 0.2965 |
| Net Debt Paydown Yield | 5.09% |